Skip to main content

Table 1 Characteristics of the patients

From: The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles

Variables

uFSH

(n = 764)

rFSH-alfa

(n = 314)

P

Age (years)

29.4 ± 3.8

29.1 ± 3.6

0.310

BMI (kg/m2)

22.4 ± 3.2

22.1 ± 3.6

0.206

Duration of infertility (years)

3.0 (2.0–5.0)

3.0 (2.0–4.0)

0.331

Basic AMH (ng/ml)

3.14 (1.95–5.11)

3.63 (2.57–5.41)

0.147

AFC

12.3 ± 4.1

13.4 ± 4.4

< 0.001

Basic FSH (IU/L)

6.21 ± 1.72

6.38 ± 1.89

0.144

Infertility type

  

0.837

 Primary

465 (60.9%)

189 (60.2%)

 

 Secondary

299 (39.1%)

125 (39.8%)

 

Primary cause of infertility

  

0.174

 Tubal

456 (76.0%)

182 (82.4%)

 

 Endometriosis

43 (7.2%)

16 (7.2%)

 

 PCOS

77 (12.8%)

15 (6.8%)

 

 Male

7 (1.2%)

3 (1.4%)

 

 Other causes

17 (2.8%)

5 (2.3%)

 

Previous number of IVF/ICSI cycles

  

0.059

 0

659 (86.3%)

284 (90.5%)

 

 1

105 (13.7%)

30 (9.6%)

 
  1. BMI body mass index; AMH anti–Müllerian hormone; AFC antral follicle count; FSH follicle-stimulating hormone; PCOS polycystic ovary syndrome; IVF in vitro fertilization; ICSI intracytoplasmic sperm injection